ChatGPT maker OpenAI’s valuation has surged to $500 billion after employees and former staff cashed out $6.6 billion worth of shares in a secondary sale, a source familiar with the deal told Reuters. With this valuation, the AI giant has left behind SpaceX and ByteDance.
The transaction lifts the artificial intelligence company’s value from $300 billion and highlights its rapid growth in both users and revenue.
The shares were purchased by investors including Thrive Capital, SoftBank, Dragoneer Investment Group, Abu Dhabi’s MGX and T Rowe Price, the source told Reuters.
OpenAI had cleared sales of more than $10 billion of stock on the secondary market, the source added.
SoftBank’s participation adds to its earlier investment in OpenAI’s $40 billion primary funding round.
Revenue at the company has also been rising sharply. OpenAI generated around $4.3 billion in the first six months of 2025, about 16% higher than its total earnings for the whole of last year, according to the Information.
The deal comes as technology firms battle to secure top AI talent with generous pay packages. Meta, for instance, has poured billions into Scale AI and recently lured its 28-year-old founder Alexandr Wang to run its new superintelligence division.
The TOI Business Desk is a vigilant and dedicated team of journal...
Read MoreThe TOI Business Desk is a vigilant and dedicated team of journalists committed to delivering the latest and most relevant business news from around the world to readers of The Times of India. The primary focus of the TOI Business Desk is to keep a watchful eye on the global business landscape, covering a wide spectrum of industries, markets, economic trends, in-depth analysis, exclusive reports and breaking stories that impact businesses and economies. With a mission to provide valuable insights and updates, the desk ensures that TOI readers are well-informed about the ever-changing and dynamic world of commerce and can navigate the complexities of the business world.
Read Less
Start a Conversation
Post comment